Evidence map›Paper›PMID 33547106›Full record

ArticleBMJ case reports2021

A rare emergence of resistance to ceftolozane/tazobactam in

Antony Arumairaj, Sanket Agarwal, Tarun Popli, Eliana Lopez

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Antony ArumairajInternal Medicine, Metropolitan Hospital Center, New York, New York, USA antojack99@gmail.com.ORCID http://orcid.org/0000-0002-3824-1657
Sanket AgarwalInternal Medicine, Metropolitan Hospital Center, New York, New York, USA.
Tarun PopliInfectious Disease, Metropolitan Hospital Center, New York, New York, USA.
Eliana LopezInfectious Disease, Metropolitan Hospital Center, New York, New York, USA.
Metropolitan Hospital Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The management of infections caused by carbapenem-resistant organisms has been a challenge. We report a rare emergence of resistance to the novel beta-lactam/ beta-lactamase combination ceftolozane/tazobactam by

Indexed as

Drug Resistance, Multiple, BacterialAgedAnti-Infective Agents, UrinaryCephalosporinsHumansKlebsiella InfectionsKlebsiella pneumoniaeMaleMicrobial Sensitivity TestsTazobactamUrinary Tract InfectionsAnti-Infective Agents, Urinaryceftolozane, tazobactam drug combinationCephalosporinsTazobactamdrugs: infectious diseasesglobal healththerapeutic indicationsurinary tract infections

Identifiers

PMID33547106
PMCPMC7871250
OpenAlexW3126490958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.